Modulation of pulmonary fibrosis by IL-13Rα2

Targeting Interleukin-13 with Tralokinumab Attenuates Lung Fibrosis and Epithelial Damage in a Humanized SCID Idiopathic Pulmonary Fibrosis Model

(2014) Lynne A. Murray et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Thymus and activation-regulated chemokine (TARC)/CC chemokine ligand (CCL) 17 accelerates wound healing by enhancing fibroblast migration

(2011) Toyoaki Kato et al.   EXPERIMENTAL DERMATOLOGY

Bleomycin and IL-1β–mediated pulmonary fibrosis is IL-17A dependent

(2010) Mark S. Wilson et al.   JOURNAL OF EXPERIMENTAL MEDICINE

IL-13R 2 Membrane and Soluble Isoforms Differ in Humans and Mice

(2009) W. Chen et al.   JOURNAL OF IMMUNOLOGY

Interleukin-13 and Its Receptors in Idiopathic Interstitial Pneumonia: Clinical Implications for Lung Function

(2009) Sung-Woo Park et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Elevated CC Chemokine Level in Bronchoalveolar Lavage Fluid Is Predictive of a Poor Outcome of Idiopathic Pulmonary Fibrosis

(2009) Hiromi Shinoda et al.   RESPIRATION

IL-13 Signaling via IL-13Rα2 Induces Major Downstream Fibrogenic Factors Mediating Fibrosis in Chronic TNBS Colitis

(2008) Stefan Fichtner–Feigl et al.   GASTROENTEROLOGY

Hyper-responsiveness of IPF/UIP fibroblasts: Interplay between TGFβ1, IL-13 and CCL2

(2008) Lynne A. Murray et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Matrix metalloproteinase 8 contributes to solubilization of IL-13 receptor α2 in vivo

(2008) Weiguo Chen et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY